In March 2025, the company declared new strategies to get a immediate-to-shopper supplying of its Wegovy weight loss drug. The company set up a completely new pharmacy, called NovoCare, which would demand consumers $499 every month for use of the drug, less than 50 percent the expense of the drug as a result of other pharmaceutical distribution net